カテゴリー： 世界, 医療/バイオ, LP Information

世界のバソプレシン拮抗薬市場予測 2023年-2029年

【英語タイトル】Global Vasopressin Antagonist Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00009）・商品コード：LP23DC00009
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：77
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のバソプレシン拮抗薬市場」は、過去の販売実績から2022年の世界のバソプレシン拮抗薬の総販売量を検討し、2023年から2029年の予測されるバソプレシン拮抗薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のバソプレシン拮抗薬の市場規模を掲載し、XXX百万米ドル規模の世界のバソプレシン拮抗薬市場の詳細な分析を提供します。本インサイトレポートは、世界のバソプレシン拮抗薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のバソプレシン拮抗薬市場における各社の独自のポジションをより深く理解するために、バソプレシン拮抗薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のバソプレシン拮抗薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。バソプレシン拮抗薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。バソプレシン拮抗薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。バソプレシン拮抗薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

バソプレシン拮抗薬の世界主要メーカーとしては、Otsuka、 Cumberland Pharmaceuticals、 Mayo Clinic、 Hopital du Sacre-Coeur de Montrealなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のバソプレシン拮抗薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではバソプレシン拮抗薬市場をセグメンテーションし、種類別 (ヴァプリゾール、トルバプタン)、用途別 (中枢性糖尿病、腎性糖尿病、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ヴァプリゾール、トルバプタン

・用途別区分：中枢性糖尿病、腎性糖尿病、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のバソプレシン拮抗薬市場の10年間の市場状況・展望は？
・世界および地域別に見たバソプレシン拮抗薬市場成長の要因は何か？
・バソプレシン拮抗薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・バソプレシン拮抗薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：バソプレシン拮抗薬の年間販売量2018-2029、地域別現状・将来分析
・バソプレシン拮抗薬の種類別セグメント：ヴァプリゾール、トルバプタン
・バソプレシン拮抗薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・バソプレシン拮抗薬の用途別セグメント：中枢性糖尿病、腎性糖尿病、その他
・バソプレシン拮抗薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のバソプレシン拮抗薬市場
・企業別のグローバルバソプレシン拮抗薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のバソプレシン拮抗薬の年間売上：2018-2023年の売上、市場シェア
・企業別のバソプレシン拮抗薬販売価格
・主要企業のバソプレシン拮抗薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

バソプレシン拮抗薬の地域別レビュー
・地域別のバソプレシン拮抗薬市場規模2018-2023：年間販売量、売上
・主要国別のバソプレシン拮抗薬市場規模2018-2023：年間販売量、売上
・南北アメリカのバソプレシン拮抗薬販売の成長
・アジア太平洋のバソプレシン拮抗薬販売の成長
・ヨーロッパのバソプレシン拮抗薬販売の成長
・中東・アフリカのバソプレシン拮抗薬販売の成長

南北アメリカ市場
・南北アメリカの国別のバソプレシン拮抗薬販売量、売上（2018-2023）
・南北アメリカのバソプレシン拮抗薬の種類別販売量
・南北アメリカのバソプレシン拮抗薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のバソプレシン拮抗薬販売量、売上（2018-2023）
・アジア太平洋のバソプレシン拮抗薬の種類別販売量
・アジア太平洋のバソプレシン拮抗薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のバソプレシン拮抗薬販売量、売上（2018-2023）
・ヨーロッパのバソプレシン拮抗薬の種類別販売量
・ヨーロッパのバソプレシン拮抗薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のバソプレシン拮抗薬販売量、売上（2018-2023）
・中東・アフリカのバソプレシン拮抗薬の種類別販売量
・中東・アフリカのバソプレシン拮抗薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・バソプレシン拮抗薬の製造コスト構造分析
・バソプレシン拮抗薬の製造プロセス分析
・バソプレシン拮抗薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・バソプレシン拮抗薬の主要なグローバル販売業者
・バソプレシン拮抗薬の主要なグローバル顧客

地域別のバソプレシン拮抗薬市場予測レビュー
・地域別のバソプレシン拮抗薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・バソプレシン拮抗薬の種類別市場規模予測
・バソプレシン拮抗薬の用途別市場規模予測

主要企業分析
Otsuka、 Cumberland Pharmaceuticals、 Mayo Clinic、 Hopital du Sacre-Coeur de Montreal
・企業情報
・バソプレシン拮抗薬製品
・バソプレシン拮抗薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Vasopressin Antagonist market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vasopressin Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vasopressin Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vasopressin Antagonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vasopressin Antagonist players cover Otsuka, Cumberland Pharmaceuticals, Mayo Clinic and Hopital du Sacre-Coeur de Montreal, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Vasopressin Antagonist Industry Forecast” looks at past sales and reviews total world Vasopressin Antagonist sales in 2022, providing a comprehensive analysis by region and market sector of projected Vasopressin Antagonist sales for 2023 through 2029. With Vasopressin Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vasopressin Antagonist industry.
This Insight Report provides a comprehensive analysis of the global Vasopressin Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vasopressin Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vasopressin Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vasopressin Antagonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vasopressin Antagonist.
This report presents a comprehensive overview, market shares, and growth opportunities of Vasopressin Antagonist market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Vaprisol
Tolvaptan
Segmentation by application
Central Diabetes Insipidus
Nephrogenic Diabetes Insipidus
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Otsuka
Cumberland Pharmaceuticals
Mayo Clinic
Hopital du Sacre-Coeur de Montreal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vasopressin Antagonist market?
What factors are driving Vasopressin Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vasopressin Antagonist market opportunities vary by end market size?
How does Vasopressin Antagonist break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vasopressin Antagonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vasopressin Antagonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vasopressin Antagonist by Country/Region, 2018, 2022 & 2029
2.2 Vasopressin Antagonist Segment by Type
2.2.1 Vaprisol
2.2.2 Tolvaptan
2.3 Vasopressin Antagonist Sales by Type
2.3.1 Global Vasopressin Antagonist Sales Market Share by Type (2018-2023)
2.3.2 Global Vasopressin Antagonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vasopressin Antagonist Sale Price by Type (2018-2023)
2.4 Vasopressin Antagonist Segment by Application
2.4.1 Central Diabetes Insipidus
2.4.2 Nephrogenic Diabetes Insipidus
2.4.3 Other
2.5 Vasopressin Antagonist Sales by Application
2.5.1 Global Vasopressin Antagonist Sale Market Share by Application (2018-2023)
2.5.2 Global Vasopressin Antagonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vasopressin Antagonist Sale Price by Application (2018-2023)
3 Global Vasopressin Antagonist by Company
3.1 Global Vasopressin Antagonist Breakdown Data by Company
3.1.1 Global Vasopressin Antagonist Annual Sales by Company (2018-2023)
3.1.2 Global Vasopressin Antagonist Sales Market Share by Company (2018-2023)
3.2 Global Vasopressin Antagonist Annual Revenue by Company (2018-2023)
3.2.1 Global Vasopressin Antagonist Revenue by Company (2018-2023)
3.2.2 Global Vasopressin Antagonist Revenue Market Share by Company (2018-2023)
3.3 Global Vasopressin Antagonist Sale Price by Company
3.4 Key Manufacturers Vasopressin Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vasopressin Antagonist Product Location Distribution
3.4.2 Players Vasopressin Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vasopressin Antagonist by Geographic Region
4.1 World Historic Vasopressin Antagonist Market Size by Geographic Region (2018-2023)
4.1.1 Global Vasopressin Antagonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vasopressin Antagonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vasopressin Antagonist Market Size by Country/Region (2018-2023)
4.2.1 Global Vasopressin Antagonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vasopressin Antagonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vasopressin Antagonist Sales Growth
4.4 APAC Vasopressin Antagonist Sales Growth
4.5 Europe Vasopressin Antagonist Sales Growth
4.6 Middle East & Africa Vasopressin Antagonist Sales Growth
5 Americas
5.1 Americas Vasopressin Antagonist Sales by Country
5.1.1 Americas Vasopressin Antagonist Sales by Country (2018-2023)
5.1.2 Americas Vasopressin Antagonist Revenue by Country (2018-2023)
5.2 Americas Vasopressin Antagonist Sales by Type
5.3 Americas Vasopressin Antagonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vasopressin Antagonist Sales by Region
6.1.1 APAC Vasopressin Antagonist Sales by Region (2018-2023)
6.1.2 APAC Vasopressin Antagonist Revenue by Region (2018-2023)
6.2 APAC Vasopressin Antagonist Sales by Type
6.3 APAC Vasopressin Antagonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vasopressin Antagonist by Country
7.1.1 Europe Vasopressin Antagonist Sales by Country (2018-2023)
7.1.2 Europe Vasopressin Antagonist Revenue by Country (2018-2023)
7.2 Europe Vasopressin Antagonist Sales by Type
7.3 Europe Vasopressin Antagonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vasopressin Antagonist by Country
8.1.1 Middle East & Africa Vasopressin Antagonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vasopressin Antagonist Revenue by Country (2018-2023)
8.2 Middle East & Africa Vasopressin Antagonist Sales by Type
8.3 Middle East & Africa Vasopressin Antagonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vasopressin Antagonist
10.3 Manufacturing Process Analysis of Vasopressin Antagonist
10.4 Industry Chain Structure of Vasopressin Antagonist
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vasopressin Antagonist Distributors
11.3 Vasopressin Antagonist Customer
12 World Forecast Review for Vasopressin Antagonist by Geographic Region
12.1 Global Vasopressin Antagonist Market Size Forecast by Region
12.1.1 Global Vasopressin Antagonist Forecast by Region (2024-2029)
12.1.2 Global Vasopressin Antagonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vasopressin Antagonist Forecast by Type
12.7 Global Vasopressin Antagonist Forecast by Application
13 Key Players Analysis
13.1 Otsuka
13.1.1 Otsuka Company Information
13.1.2 Otsuka Vasopressin Antagonist Product Portfolios and Specifications
13.1.3 Otsuka Vasopressin Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Otsuka Main Business Overview
13.1.5 Otsuka Latest Developments
13.2 Cumberland Pharmaceuticals
13.2.1 Cumberland Pharmaceuticals Company Information
13.2.2 Cumberland Pharmaceuticals Vasopressin Antagonist Product Portfolios and Specifications
13.2.3 Cumberland Pharmaceuticals Vasopressin Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cumberland Pharmaceuticals Main Business Overview
13.2.5 Cumberland Pharmaceuticals Latest Developments
13.3 Mayo Clinic
13.3.1 Mayo Clinic Company Information
13.3.2 Mayo Clinic Vasopressin Antagonist Product Portfolios and Specifications
13.3.3 Mayo Clinic Vasopressin Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mayo Clinic Main Business Overview
13.3.5 Mayo Clinic Latest Developments
13.4 Hopital du Sacre-Coeur de Montreal
13.4.1 Hopital du Sacre-Coeur de Montreal Company Information
13.4.2 Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Product Portfolios and Specifications
13.4.3 Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hopital du Sacre-Coeur de Montreal Main Business Overview
13.4.5 Hopital du Sacre-Coeur de Montreal Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Vasopressin Antagonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vasopressin Antagonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaprisol
Table 4. Major Players of Tolvaptan
Table 5. Global Vasopressin Antagonist Sales by Type (2018-2023) & (K Units)
Table 6. Global Vasopressin Antagonist Sales Market Share by Type (2018-2023)
Table 7. Global Vasopressin Antagonist Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vasopressin Antagonist Revenue Market Share by Type (2018-2023)
Table 9. Global Vasopressin Antagonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Vasopressin Antagonist Sales by Application (2018-2023) & (K Units)
Table 11. Global Vasopressin Antagonist Sales Market Share by Application (2018-2023)
Table 12. Global Vasopressin Antagonist Revenue by Application (2018-2023)
Table 13. Global Vasopressin Antagonist Revenue Market Share by Application (2018-2023)
Table 14. Global Vasopressin Antagonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Vasopressin Antagonist Sales by Company (2018-2023) & (K Units)
Table 16. Global Vasopressin Antagonist Sales Market Share by Company (2018-2023)
Table 17. Global Vasopressin Antagonist Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vasopressin Antagonist Revenue Market Share by Company (2018-2023)
Table 19. Global Vasopressin Antagonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Vasopressin Antagonist Producing Area Distribution and Sales Area
Table 21. Players Vasopressin Antagonist Products Offered
Table 22. Vasopressin Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vasopressin Antagonist Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vasopressin Antagonist Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vasopressin Antagonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vasopressin Antagonist Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vasopressin Antagonist Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vasopressin Antagonist Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vasopressin Antagonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vasopressin Antagonist Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vasopressin Antagonist Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vasopressin Antagonist Sales Market Share by Country (2018-2023)
Table 35. Americas Vasopressin Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vasopressin Antagonist Revenue Market Share by Country (2018-2023)
Table 37. Americas Vasopressin Antagonist Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vasopressin Antagonist Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vasopressin Antagonist Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vasopressin Antagonist Sales Market Share by Region (2018-2023)
Table 41. APAC Vasopressin Antagonist Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vasopressin Antagonist Revenue Market Share by Region (2018-2023)
Table 43. APAC Vasopressin Antagonist Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vasopressin Antagonist Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vasopressin Antagonist Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vasopressin Antagonist Sales Market Share by Country (2018-2023)
Table 47. Europe Vasopressin Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vasopressin Antagonist Revenue Market Share by Country (2018-2023)
Table 49. Europe Vasopressin Antagonist Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vasopressin Antagonist Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vasopressin Antagonist Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vasopressin Antagonist Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vasopressin Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vasopressin Antagonist Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vasopressin Antagonist Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vasopressin Antagonist Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vasopressin Antagonist
Table 58. Key Market Challenges & Risks of Vasopressin Antagonist
Table 59. Key Industry Trends of Vasopressin Antagonist
Table 60. Vasopressin Antagonist Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vasopressin Antagonist Distributors List
Table 63. Vasopressin Antagonist Customer List
Table 64. Global Vasopressin Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vasopressin Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vasopressin Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vasopressin Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vasopressin Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vasopressin Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vasopressin Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vasopressin Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vasopressin Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vasopressin Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vasopressin Antagonist Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vasopressin Antagonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vasopressin Antagonist Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vasopressin Antagonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Otsuka Basic Information, Vasopressin Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 79. Otsuka Vasopressin Antagonist Product Portfolios and Specifications
Table 80. Otsuka Vasopressin Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Otsuka Main Business
Table 82. Otsuka Latest Developments
Table 83. Cumberland Pharmaceuticals Basic Information, Vasopressin Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 84. Cumberland Pharmaceuticals Vasopressin Antagonist Product Portfolios and Specifications
Table 85. Cumberland Pharmaceuticals Vasopressin Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Cumberland Pharmaceuticals Main Business
Table 87. Cumberland Pharmaceuticals Latest Developments
Table 88. Mayo Clinic Basic Information, Vasopressin Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 89. Mayo Clinic Vasopressin Antagonist Product Portfolios and Specifications
Table 90. Mayo Clinic Vasopressin Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Mayo Clinic Main Business
Table 92. Mayo Clinic Latest Developments
Table 93. Hopital du Sacre-Coeur de Montreal Basic Information, Vasopressin Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 94. Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Product Portfolios and Specifications
Table 95. Hopital du Sacre-Coeur de Montreal Vasopressin Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Hopital du Sacre-Coeur de Montreal Main Business
Table 97. Hopital du Sacre-Coeur de Montreal Latest Developments
List of Figures
Figure 1. Picture of Vasopressin Antagonist
Figure 2. Vasopressin Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vasopressin Antagonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vasopressin Antagonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vasopressin Antagonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaprisol
Figure 10. Product Picture of Tolvaptan
Figure 11. Global Vasopressin Antagonist Sales Market Share by Type in 2022
Figure 12. Global Vasopressin Antagonist Revenue Market Share by Type (2018-2023)
Figure 13. Vasopressin Antagonist Consumed in Central Diabetes Insipidus
Figure 14. Global Vasopressin Antagonist Market: Central Diabetes Insipidus (2018-2023) & (K Units)
Figure 15. Vasopressin Antagonist Consumed in Nephrogenic Diabetes Insipidus
Figure 16. Global Vasopressin Antagonist Market: Nephrogenic Diabetes Insipidus (2018-2023) & (K Units)
Figure 17. Vasopressin Antagonist Consumed in Other
Figure 18. Global Vasopressin Antagonist Market: Other (2018-2023) & (K Units)
Figure 19. Global Vasopressin Antagonist Sales Market Share by Application (2022)
Figure 20. Global Vasopressin Antagonist Revenue Market Share by Application in 2022
Figure 21. Vasopressin Antagonist Sales Market by Company in 2022 (K Units)
Figure 22. Global Vasopressin Antagonist Sales Market Share by Company in 2022
Figure 23. Vasopressin Antagonist Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Vasopressin Antagonist Revenue Market Share by Company in 2022
Figure 25. Global Vasopressin Antagonist Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Vasopressin Antagonist Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Vasopressin Antagonist Sales 2018-2023 (K Units)
Figure 28. Americas Vasopressin Antagonist Revenue 2018-2023 ($ Millions)
Figure 29. APAC Vasopressin Antagonist Sales 2018-2023 (K Units)
Figure 30. APAC Vasopressin Antagonist Revenue 2018-2023 ($ Millions)
Figure 31. Europe Vasopressin Antagonist Sales 2018-2023 (K Units)
Figure 32. Europe Vasopressin Antagonist Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Vasopressin Antagonist Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Vasopressin Antagonist Revenue 2018-2023 ($ Millions)
Figure 35. Americas Vasopressin Antagonist Sales Market Share by Country in 2022
Figure 36. Americas Vasopressin Antagonist Revenue Market Share by Country in 2022
Figure 37. Americas Vasopressin Antagonist Sales Market Share by Type (2018-2023)
Figure 38. Americas Vasopressin Antagonist Sales Market Share by Application (2018-2023)
Figure 39. United States Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Vasopressin Antagonist Sales Market Share by Region in 2022
Figure 44. APAC Vasopressin Antagonist Revenue Market Share by Regions in 2022
Figure 45. APAC Vasopressin Antagonist Sales Market Share by Type (2018-2023)
Figure 46. APAC Vasopressin Antagonist Sales Market Share by Application (2018-2023)
Figure 47. China Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Vasopressin Antagonist Sales Market Share by Country in 2022
Figure 55. Europe Vasopressin Antagonist Revenue Market Share by Country in 2022
Figure 56. Europe Vasopressin Antagonist Sales Market Share by Type (2018-2023)
Figure 57. Europe Vasopressin Antagonist Sales Market Share by Application (2018-2023)
Figure 58. Germany Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Vasopressin Antagonist Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Vasopressin Antagonist Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Vasopressin Antagonist Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Vasopressin Antagonist Sales Market Share by Application (2018-2023)
Figure 67. Egypt Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Vasopressin Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Vasopressin Antagonist in 2022
Figure 73. Manufacturing Process Analysis of Vasopressin Antagonist
Figure 74. Industry Chain Structure of Vasopressin Antagonist
Figure 75. Channels of Distribution
Figure 76. Global Vasopressin Antagonist Sales Market Forecast by Region (2024-2029)
Figure 77. Global Vasopressin Antagonist Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Vasopressin Antagonist Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Vasopressin Antagonist Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Vasopressin Antagonist Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Vasopressin Antagonist Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のバソプレシン拮抗薬市場予測 2023年-2029年] (コード：LP23DC00009)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバソプレシン拮抗薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のカリウム競合拮抗薬市場予測 2023年-2029年
  • 世界の短時間睡眠症候群治療市場予測 2023年-2029年
  • 世界のバソプレシンV1b受容体市場予測2023-2029：PHT-103、ABT-436、AVN-628、その他
  • 世界のメチシリン耐性黄色ブドウ球菌感染症用治療薬市場予測 2023年-2029年
  • 世界のラディザクト市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆